🔗 Visit the ClinicalTrials.gov page for NCT00831441
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Apixaban with antiplatelet therapy after acute coronary syndrome. | N Engl J Med | 2011 | 4.81 |
| 2 | Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial. | J Am Coll Cardiol | 2015 | 1.41 |
| 3 | The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. | Nat Rev Drug Discov | 2010 | 1.33 |
| 4 | New antithrombotic agents--insights from clinical trials. | Nat Rev Cardiol | 2010 | 0.84 |
| 5 | Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes. | J Am Heart Assoc | 2015 | 0.78 |
| 6 | Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome. | Heart | 2015 | 0.75 |